Skip to content

HAART and harvest: antiretroviral therapy and nutrition when food is scarce

3 million on treatment target unlikely to be met by end of 2005, says WHO

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Efavirenz reduces blood statin concentrations

Bristol Myers Squibb to cut price of two HIV drugs for children

Brazil warns of generic Kaletra unless Abbott halves price within 10 days

Tipranavir receives US marketing approval

Generic efavirenz approved for PEPFAR use but 4 African countries reject US drug standard

HAART during primary HIV infection restores interferon production